Follow
Michael A. Rogawski
Michael A. Rogawski
Professor of Neurology and Pharmacology, University of California,Davis
Verified email at ucdavis.edu - Homepage
Title
Cited by
Cited by
Year
The neurobiology of antiepileptic drugs
MA Rogawski, W Löscher
Nature reviews neuroscience 5 (7), 553-564, 2004
14552004
d-Serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor
JP Mothet, AT Parent, H Wolosker, RO Brady Jr, DJ Linden, CD Ferris, ...
Proceedings of the National Academy of Sciences 97 (9), 4926-4931, 2000
13572000
Antiepileptic drugs Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds
MA Rogawski
Pharmacol. Rev. 42, 223-286, 1990
9291990
Glia and epilepsy: excitability and inflammation
O Devinsky, A Vezzani, S Najjar, NC De Lanerolle, MA Rogawski
Trends in neurosciences 36 (3), 174-184, 2013
8442013
Neuroprotective and disease-modifying effects of the ketogenic diet
M Gasior, MA Rogawski, AL Hartman
Behavioural pharmacology 17 (5-6), 431-439, 2006
6392006
Molecular targets for antiepileptic drug development
BS Meldrum, MA Rogawski
Neurotherapeutics 4 (1), 18-61, 2007
5942007
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions
MA Rogawski, W Löscher
Nature medicine 10 (7), 685-692, 2004
5662004
The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease
MA Rogawski, GL Wenk
CNS drug reviews 9 (3), 275-308, 2003
5512003
Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304
JA French, GL Krauss, V Biton, D Squillacote, H Yang, A Laurenza, ...
Neurology 79 (6), 589-596, 2012
5472012
Colchicine myopathy and neuropathy
RW Kuncl, G Duncan, D Watson, K Alderson, MA Rogawski, M Peper
New England Journal of Medicine 316 (25), 1562-1568, 1987
5001987
GYKI 52466, a 2, 3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses
SD Donevan, MA Rogawski
Neuron 10 (1), 51-59, 1993
4401993
Anticonvulsant activity of neurosteroids: correlation with gamma-aminobutyric acid-evoked chloride current potentiation.
TG Kokate, BE Svensson, MA Rogawski
Journal of Pharmacology and Experimental Therapeutics 270 (3), 1223-1229, 1994
4371994
Diverse mechanisms of antiepileptic drugs in the development pipeline
MA Rogawski
Epilepsy research 69 (3), 273-294, 2006
4332006
Revisiting AMPA receptors as an antiepileptic drug target: revisiting AMPA receptors as an antiepileptic drug target
MA Rogawski
Epilepsy currents 11 (2), 56-63, 2011
4182011
Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2, 3-benzodiazepines
MA Rogawski
Trends in pharmacological sciences 14 (9), 325-331, 1993
4151993
The A-current: how ubiquitous a feature of excitable cells is it?
MA Rogawski
Trends in Neurosciences 8, 214-219, 1985
4101985
The neuropharmacology of the ketogenic diet
AL Hartman, M Gasior, EPG Vining, MA Rogawski
Pediatric neurology 36 (5), 281-292, 2007
3912007
“Jasper’s basic mechanisms of the epilepsies” workshop
JL Noebels, M Avoli, M Rogawski, R Olsen, AV Delgado‐Escueta
Epilepsia 51, 1-5, 2010
351*2010
Stress-induced deoxycorticosterone-derived neurosteroids modulate GABAA receptor function and seizure susceptibility
DS Reddy, MA Rogawski
Journal of Neuroscience 22 (9), 3795-3805, 2002
3232002
Mechanisms of action of antiseizure drugs and the ketogenic diet
MA Rogawski, W Löscher, JM Rho
Cold Spring Harbor perspectives in medicine 6 (5), a022780, 2016
3092016
The system can't perform the operation now. Try again later.
Articles 1–20